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ABSTRACT
Introduction Although the impact of macrolevel 
characteristics of health systems on socioeconomic 
inequity in health has been studied extensively, the 
impact of access characteristics on a smaller scale 
of health systems has received less attention. These 
mesolevel characteristics can influence access to 
healthcare and might have the potential to moderate or 
aggravate socioeconomic inequity in healthcare use. This 
scoping review aims to map the existing evidence of the 
association of socioeconomic inequity in healthcare use 
and mesolevel access characteristics of the health system.
Methods and analysis In conducting the scoping review, 
we follow the Preferred Reporting Items for Systematic 
Review and Meta- Analysis Protocols Extension for Scoping 
Reviews. The search will be carried out in four scientific 
databases: MEDLINE (via PubMed), Web of Science, 
Scopus and PsycINFO. Main eligibility criteria are inclusion 
in the analysis of a measure of socioeconomic position, 
a measure of individual healthcare use and a mesolevel 
determinant of access to healthcare services. The 
selection process consists of two consecutive screening 
stages (first: title/abstract; second: full text). At both 
stages, two reviewers independently assess the eligibility 
of studies. In case of disagreement, a third reviewer will 
be involved. Cohen’s kappa will be calculated to report 
inter- rater agreement between reviewers. Results are 
synthesised narratively, as a high heterogeneity of studies 
is expected.
Ethics and dissemination No primary data are collected 
for the presented scoping review. Therefore, ethical 
approval is not necessary. The scoping review will be 
published in an international peer- reviewed journal, and 
findings will be presented on national and international 
conferences.
INTRODUCTION
The existence of a social gradient in health 
is undisputed: lower levels of socioeconomic 
position (SEP) are associated with higher 
levels of morbidity and mortality.1 Similarly 
acknowledged is the fact that the design and 
management of health systems are crucial in 
achieving health equity.2 3 In recent decades, 
a large body of research has focused on iden-
tifying health system structures and elements 
addressing health equity. The discourse on 
equity and inequity in health and the role 
of health systems were further enhanced by 
multiple and international policy actions, for 
example, the establishment of the WHO’s 
Health System Knowledge Network,2 or the 
definition and increasing use of concepts such 
as universal health coverage.4 This research 
and action ultimately reveal and emphasise 
the potential and also the responsibility of 
health systems to contribute to achieving 
health equity.2 3 5 A key concept in the context 
of health equity is ‘access to healthcare’. 
Equity in access, as highlighted in the defini-
tion of universal health coverage,6 7 represents 
the premise for equity in health.6–11 In evalu-
ating and analysing equity in access and the 
role of health systems at this, ‘healthcare 
use’ plays a crucial role.12 In the notion of 
Strengths and limitations of this study
 ► This protocol describes the first scoping review 
focusing on the association of socioeconomic in-
equality in healthcare use and mesolevel access 
characteristics of the healthcare system.
 ► The proposed scoping review adopts a broad scope 
in order to identify any mesolevel factors that might 
moderate, aggravate or correlate with socioeco-
nomic inequity in healthcare use.
 ► Only studies that include a measure of socioeco-
nomic position, a measure of healthcare use and 
mesolevel access characteristics of the health sys-
tem will be eligible for review.
 ► The proposed scoping review is limited to studies 
from high- income countries to increase comparabil-
ity of findings and, thus, will not capture evidence 
from middle- income and low- income countries.
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Andersen,12 healthcare use can be regarded as a measure 
of the realised, ‘effective access’ and is a commonly used 
measure to depict access and socioeconomic differences 
in access.13–18
Common policies and health system characteristics that 
are studied in the context of equity in access, equity in 
healthcare use and equity in health focus on macrolevel 
characteristics that are usually defined by national legisla-
tion.19–21 They include, among others, the national density 
of human resources for health,22 the level of national 
health expenditure,23 the extent to which patients are 
obliged to copay medication and the presence of a gate-
keeping system.21 A prominent policy example is repre-
sented by the US Medicaid programme, which provides 
health insurance mainly for people with low SEP, thereby 
targeting the access dimension of affordability by 
decreasing financial barriers to insurance coverage.24 25
Many high- income countries already perform well with 
respect to these indicators, with a relatively high level of 
national health expenditure and insurance coverage for 
the entire population. Yet, inequalities in the use of health-
care and health outcomes are still evident in all different 
types of healthcare systems.14 26–28 Undoubtedly, these 
inequalities are of complex and multifactorial origin, and 
efforts from many policy sectors, including other than 
health, are required to improve the situation.3 However, 
with the past focus on macrolevel measures at a national 
level, the question arises whether and to what extent 
health systems of high- income countries may include 
unexploited potential to increase equity in health and 
healthcare use through adjustments in the health system 
at a smaller level. We refer to this level as ‘mesolevel’, as 
it lies below the just mentioned macrolevel, but has to be 
distinguished from the individual level, which is charac-
terised by personal characteristics (cf. figure 1).29 30
While the macrolevel access characteristics of the 
health system have been studied extensively in the 
context of equity, the mesolevel access characteristics 
appear to have not been investigated as much. This 
might also reflect the challenge to accurately define a 
mesolevel of the health system. The meaning of the term 
in the health system’s context differs by authors,29 31 32 yet 
shares some basic similarities: they subsume characteris-
tics of structures of the health system at a smaller than 
national scale, which usually are not directly part of the 
national health policy responsibility and are thus often 
defined by geographical region (eg, by county or district) 
and are referred to as ‘regional’ characteristics. Kramer 
et al29 highlight the importance of the health system’s 
mesolevel, defining it ‘[…] as the institutions and estab-
lishments that children and their families interact with 
on a regular basis’. Following this understanding, the 
local design of health services and the structure of the 
supply side, for example, the local density of physicians, 
are what determine the interaction between patients 
and the health system on a mesolevel. These contextual 
characteristics of the health system’s mesolevel might 
influence access to healthcare, especially in terms of 
‘accomodation’ (eg, appointment systems and office 
hours), ‘accessibility’ (eg, travel time, distance and cost) 
and ‘availability’ (eg, regional physician density), as 
termed by Penchansky and Thomas,10 and consequently 
the use of health services (cf. figure 1). Thus, the design 
of the healthcare system at this smaller scale of the 
mesolevel should not be overlooked when inequity in 
health and healthcare use is investigated.
Figure 1 Framework to distinguish the macrolevel and mesolevel of the health system.
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It is therefore of interest to study and evaluate the 
role and impact of mesolevel access characteristics of 
the healthcare system in the relationship between SEP 
and health or healthcare use. To prepare such research, 
we have to identify the characteristics of the healthcare 
system that potentially impact on socioeconomic differ-
ences in access to healthcare at a mesolevel. To date, a 
comprehensive literature review of mesolevel access 
characteristics of the health system and their influence 
on socioeconomic inequity in healthcare use is missing. 
Therefore, the scoping review presented here aims to 
answer the following research question:
Which mesolevel access characteristics of the health 
system influence, moderate or aggravate socioeconomic 
inequality in healthcare use?
We review research investigating the impact of mesolevel 
characteristics of the health system on the correlation 
between SEP and healthcare use. Our aim is to gain a 
comprehensive overview on the mesolevel characteris-
tics that have been researched in this context. Further, 
we seek to understand which of these characteristics play 
potentially a mediating, moderating or aggravating role 
with regard to socioeconomic inequity in healthcare use 
and should be focused on in future research.
The scoping review presented here will be undertaken 
in the context of the research unit FOR2723, ‘Under-
standing the institutional context of health inequalities 
among young people. A life stage approach’, which is 
funded by the German Research Foundation.33 Results of 
the scoping review will provide the basis for further anal-
yses of one of the research unit’s subprojects, focusing on 
the role of the healthcare system’s mesolevel for socio-
economic inequality in healthcare use especially of young 
people.
This review adopts a broad approach and focuses on 
a population of any age, not only young people. Thus, 
we follow the idea that a health system characteristic that 
has been shown to influence socioeconomic inequality in 
healthcare use in a population of any age is most likely 
also to be relevant in the context of children and young 
people. However, as part of the narrative synthesis, the 
evidence will also be mapped for results that may be 
specific to children and adolescents.
METHODS AND ANALYSIS
We decided to conduct a scoping review because it 
represents a tool to determine the extent of the avail-
able evidence on a topic, to map the evidence in a full 
Table 1 Overview of inclusion and exclusion criteria
  Inclusion Exclusion
Study 
designs
Original and peer- reviewed 
research:
 ► Case studies




 ► Qualitative studies  ► Animal 
studies
 ► Cell studies
 ► Reviews*
Population No restriction
Country High- income countries 





or low- income 
countries
Australia, Austria, Belgium, 
Bulgaria, Canada, Croatia, 
Cyprus, Czech Republic, 
Denmark, Estonia, Finland, 
France, Germany, Greece, 
Hungary, Iceland, Ireland, 
Italy, Japan, Latvia, 
Lithuania, Luxembourg, 
Malta, Netherlands, New 
Zealand, Norway, Poland, 





1. Any measure used to 
indicate the socioeconomic 
position, such as
  
 ► Educational status
 ► Income
 ► Deprivation
 ► Occupational status
  2. Determinants of access at 
the mesolevel, for example,
Determinants 
of access at the 
macrolevel, for 
example,
 ► Physician density at a 
regional level
 ► Insurance 
status
 ► Distance/travel time  ► Provider 
payment 
schemes
 ► Consultation/office hours
Outcomes Any measure of individual 
healthcare use
 ► Health status






Languages German, English Other 
languages
Continued
  Inclusion Exclusion
Publication 
date
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research area and to identify gaps in the evidence body. 
In general, scoping reviews address broader research 
questions.34 We conduct the scoping review according to 
guidance provided by the Preferred Reporting Items for 
Systematic Review and Meta- Analysis Protocols Extension 
for Scoping Reviews35 and the Joanna Briggs Institute.34
Inclusion criteria
We deduced three criteria that a study has to meet to be 
eligible for inclusion:
1. Measures of individual healthcare use must be 
reported.
2. Mesolevel determinants of access or mesolevel access 
characteristics of the health system must be reported 
or included in the analysis.
3. Measures of SEP must be included in the analysis.
In the following text, we describe the inclusion and 
exclusion criteria in more detail; an overview of these 
criteria is given in table 1.
Participants
There will be no restriction on participant type in terms 
of age, gender or morbidity, although the specific aim 
of the project, to which this scoping review belongs, was 
to understand inequity in the healthcare use of chil-
dren and adolescents. This review is intended to identify 
potentially relevant characteristics at the mesolevel of 
the health system that are worthy of thorough analysis 
with respect to this overall aim. The decision to include 
all populations follows the rationale that characteristics 
showing correlations with SEP and healthcare use at the 
mesolevel for any type of patient should be regarded as 
potential candidates for relevance to inequity in children 
and adolescents, too.
Outcomes
The outcomes of interest are measures of health services 
use, such as ‘number of physician visits’. Studies inves-
tigating the use of healthcare are eligible for inclusion. 
In turn, this means that studies investigating solely 
health, health status or health behaviour as outcomes are 
excluded.
Context and determinants of interest
The focus of this review is on mesolevel access characteris-
tics of the health system. Eligibility is therefore restricted 
to studies investigating access to health services at a 
mesolevel, such as ‘regional average travel time to nearest 
physician’ or ‘local physician density’. Studies focusing 
on macrolevel determinants of access, such as payment 
schemes or insurance schemes that are decided on at a 
national level, will be excluded. Also, studies investigating 
specific health policies such as the sending of motivation 
letters will be excluded.
A further eligibility criterion constitutes the inclusion of 
a measure of SEP in the study or analysis, such as income 
or educational status.
Types of studies
In line with the characteristics of a scoping review, various 
quantitative study designs (eg, cross- sectional studies, 
prospective studies, cohort studies and case–control 
studies) but also qualitative ones are eligible for inclu-
sion. Case, animal or cell studies will be excluded. Also, 
only original and peer- reviewed research is considered; 
commentaries, letters or statements will be excluded. 
The inclusion criterion regarding study types might be 
subjected to change, if findings are limited. In this case, 
also other types of research as grey literature or reports 
will be eligible. This would also imply adjustment of the 
extent of quality assessment of the evidence. Reviews are 
not eligible, although they will be screened for further 
relevant publications.
To increase comparability and transferability of the 
findings across countries, only publications studying 
populations from high- income countries (according to 
the category of ‘developed economies’ in the classifica-
tion of the United Nations36) will be considered, as health 
systems, determinants of health services accessibility and 
socioeconomic disparities differ significantly between 
high- income, middle- income and low- income countries.
The search is restricted to articles written in English or 
German and published between 1 January 2000 and 31 
March 2020.
Search strategy
The following four scientific literature databases will 
be searched: MEDLINE (via PubMed), Web of Science, 
Scopus and PsycINFO. The search strategy is composed 
of three thematic blocks of keywords, reflecting the three 
main inclusion criteria. These three blocks are connected 
with the Boolean Operator AND. The first block 
comprises keywords and phrases for ‘healthcare use’. 
The second block describes the mesolevel context of the 
healthcare system and is split into two ‘AND’-connected 
sub- blocks: a block containing OR- connected descrip-
tors of regional factors and a block comprising a variety 
of synonyms for ‘access’ or specific access measures. The 
third block covers the ‘SEP’ and a variety of terms related 
to SEP. The defined keywords are searched within title 
and abstract fields. In addition, if applicable (PubMed 
and PsycINFO), appropriate Medical Subject Headings 
terms were searched too. An overview of all terms used is 
given in table 2.
Further, the search strategy comprises the restriction 
in terms of language and publication date, as detailed 
previously. Other inclusion/exclusion criteria (such as 
the country criterion) are applied within the selection 
process and are not reflected in the search strategy. 
The full search strategies for each database search are 
provided in the online supplemental appendix.
Study selection process
The selection process will consist of two screening stages: 
in the first step, title and abstract will be examined; in the 
second step, a full- text review will be conducted for those 
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papers included after the first step. Both screening phases 
will be conducted independently by two reviewers (WS 
and AN) based on a set of previously defined inclusion and 
exclusion criteria (cf. table 1). The two reviewers agree 
in advance on a hierarchy of the inclusion/exclusion 
criteria to follow. The applicability of these and the hier-
archy has been pretested in an exemplary test selection 
by both reviewers independently (n=100). To determine 
inter- rater agreement between reviewers, we will calcu-
late Cohen’s Kappa after both phases. Disagreements will 
be resolved by discussion between the reviewers. In case 
consensus cannot be achieved, a third reviewer (LS) will 
take the final decision. The study selection process will be 
documented in detail.
The search will be performed on the websites of the 
mentioned databases. EndNote will be used to combine 
search results and to manage duplicates. Thereafter, 
search results will be imported to Rayyan,37 where the 
study selection process will be performed. Included 
studies will finally be imported to EndNote and/or Citavi 
for further steps, such as data extraction and results 
synthesis.
Data extraction
A predefined data extraction form will be used to extract 
relevant data from included studies. The data extraction 
form may be refined at the review stage, if necessary. It 
includes at least
 ► Title, author and year of publication
 ► Origin/country of origin
 ► Year of study execution
 ► Study design and relevant methods
 ► Aims of the study
 ► Population
 ► Healthcare use: how was it measured? Which type of 
health services?














Two sub- blocks: (descriptors within 
search block are 
connected with OR):
 ► Health 
services 
underuse
Sub- block ‘regional’ 
AND sub- block 
‘access measures’
 ► Economic level
 ► Healthcare- 
seeking 
behaviour
   ► Assets index




Sub- block regional:  ► Socioeconomic 
position
 ► Delivery of 
healthcare
(descriptors within 
search block are 
connected with OR):
 ► Health status 
disparities
 ► Medical 
overuse
 ► Region  ► Health equity
 ► Health 
services 
overuse
 ► Neighbourhood  ► Social 
determinants of 
health
 ► Health 
services 
overuse
 ► Geographical  ► Healthcare 
disparities
 ► Healthcare 
use
 ► Local  ► Healthcare 
inequalities
 ► Health 
services use
 ► Spatial  ► Socioeconomic 
position
 ► Physician 
visits
 ► Borough  ► Socioeconomic 
factors
 ► Paediatrician 
visits
   ► Social class
 ► Children’s 
doctor visits
   ► Socioeconomic 
status
 ► Baby doctor 
visits
Sub- block ‘access 
measures’:
 ► Social gradient
 ► Referral and 
consultation
(descriptors within 
search block are 
connected with OR):
 ► Inequity
   ► Health services 
accessibility
 ► Inequality
   ► Access to 
healthcare
 ► Gap
   ► Availability of 
health services
 ► Poverty
   ► Travel times  ► Deprivation
   ► Travel distance  ► Education











   ► Hospital beds  ► Income
   ► Physician density  ► Family income
   ► Paediatrician 
density
 ► Schooling




   ► Healthcare supply   
   ► Office hours   
   ► Consultation 
hours
  
Descriptors were searched in the title and abstract fields. Terms 
that were also used as Medical Subject Headings terms are 
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 ► Access: which mesolevel access characteristic of the 
health system was studied?
 ► SEP: how was SEP measured/operationalised?
 ► Key findings
Even though a critical appraisal in terms of study quality 
is not part of scoping reviews by default, we will extract 
basic characteristics related to study quality (for example 
the size of study population, limitations reported by 
authors, as well as further characteristics related to risk 
of bias depending on study design). Data extraction will 
be performed independently by two authors (WS and 
AN). Disagreements will be solved by discussion or, if no 
consensus can be reached, by a third author’s decision 
(LS). During the data extraction process, multiple articles 
of the same study may be identified within the included 
studies. These will remain included, if they differ in the 
information they provide. Otherwise the most extensive 
version of the analysis is used.
Data synthesis
Data will be synthesised narratively, as high heterogeneity 
of studies is expected on account of the broad nature of 
the question. The aim is to provide a structured synthesis 
to reveal the main identified health system characteris-
tics of interest. Subgroup analyses of specific population 
groups such as children and adolescents are planned.
ETHICS AND DISSEMINATION
No primary data are collected for this scoping review. 
Therefore, ethical approval is not required. This study 
protocol will be published in advance. The findings of the 
review will be published in an international peer- reviewed 
journal and may be presented at national or international 
conferences.
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